INTRODUCTION
============

MicroRNAs (miRNAs) are a continuously growing class of small RNAs that act as guides in the translational silencing and degradation of target mRNAs ([@B1]). Many miRNAs are conserved over large evolutionary distances such as between human and worm ([@B2]). Fundamental biological processes such as development ([@B3]--[@B6]), metabolism ([@B7]--[@B9]), cardiac ([@B10]) and immune system function ([@B11]) have been shown to be regulated by miRNAs, and aberrant miRNA expression has been associated with cancers ([@B12],[@B13]).

There are various approaches to miRNA expression profiling, one of which is small RNA sequencing. Classical cloning and sequencing of size-separated small RNAs have been used to generate a large atlas of miRNA expression profiles ([@B14]), and this approach can be scaled up considerably through deep sequencing technologies ([@B15]). Microarray-based expression profiling is also a popular approach, which has been used for instance to characterize the miRNA expression cancer samples ([@B12]). In contrast to sequencing, microarray-based profiling does not allow identification of novel miRNAs.

Numerous approaches have also been proposed for miRNA target prediction. Because the 5′-end of miRNAs (known as 'seed') appears to be important for target recognition, a number of tools focus on the evolutionary conservation of miRNA seed-complementary regions in 3′-UTRs ([@B16]--[@B19]). Other approaches emphasize the energy of hybridization between miRNA and target ([@B20]--[@B22]), the expected anti-correlation between the expression level of miRNAs and their mRNA targets ([@B23],[@B24]), the properties of the environment of the miRNA target site ([@B25],[@B26]) or combine various features of the miRNA target site itself ([@B27],[@B28]).

Studies in both native expression ([@B29]) as well as transfection-induced miRNA overexpression situations ([@B30],[@B31]) indicate that within a given tissue, the miRNAs that are most strongly expressed have the largest impact on mRNA targets. For this reason, deciphering the miRNA-dependent post-transcriptional regulatory layer in a given tissue or cell type needs to start from the miRNA expression profile of that tissue or cell type. Conversely, it is very common that one identifies differences in miRNA expression between cells at various stages of differentiation or between normal and malignant cells, and the natural question is what mRNAs are most likely to be affected by the change in miRNA expression. To address these types of questions, we developed MirZ ([www.mirz.unibas.ch](www.mirz.unibas.ch)), a web service that integrates two resources that we developed in the context of previous research projects: the smiRNAdb miRNA expression atlas ([@B14]), and the ElMMo miRNA target prediction algorithm ([@B18]).

MATERIALS AND METHODS
=====================

The smiRNAdb miRNA expression atlas
-----------------------------------

smiRNAdb ([@B14]) is a unique, web-accessible and widely used resource of miRNA profiles determined by sequencing from hundreds of *Homo sapiens*, *Mus musculus* and *Rattus norvegicus* samples. The web interface of smiRNAdb features an extended repertoire of on-line analyses such as visualization and hierarchical clustering of miRNA expression profiles, principal component analysis, comparison of miRNA expression between two (sets of) samples with the aim of identifying the miRNAs whose expression differs most between the samples. We used the Brenda tissue ontology ([@B32],[@B33]) as a guide in organizing the samples such that the user can readily identify related cell lineages or normal and pathological samples derived from a given tissue type. Our tissue hierarchy has four levels: the organ/system (e.g. hematopoietic system), subsystem (e.g. lymphoid lineage), cell type (e.g. B cell) and further cell type classification (e.g. B lymphocyte). MiRNAs themselves can be analyzed independently, grouped by their 2--7 subsequence, or grouped in precursor clusters. Two miRNAs are placed in the same precursor cluster if their loci are within 50 kb of each other in the genome, or if they share a mature form.

As an example, one may be interested in comparing miRNA expression between effector and naive human CD4^+^ T lymphocytes. SmiRNAdb features a 'Sample comparison' tool, which was specifically designed for the pairwise comparison of miRNA (sets of) samples. The user would select to compare the sample named 'hsa_T-cell-CD4-effector' to the sample named 'hsa_T-cell-CD4-naive'. Because the naive CD4^+^ T cell sample and the effector CD4^+^ T cell sample differ widely in the total number of sequenced miRNAs (1374 versus 89), the precision of the miRNA frequency estimates in the two samples will also be very different. This situation is common in sequencing-based datasets making the identification of miRNAs whose expression is *significantly* different a non-trivial problem. At the heart of the tools offered by smiRNAdb, however, is a Bayesian model for computing the posterior probability that the *frequency* of a miRNA in the total miRNA population differs between two (sets of) samples. We compute this probability assuming a binomial sampling model and integrating over the unknown miRNA frequencies in the samples. This approach---described in details in Berninger *et al.* ([@B34])---takes into account both the variability between sample sizes and the absolute miRNA counts.

[Figure 1](#F1){ref-type="fig"} shows the results of comparing the miRNA expression profiles of naive versus effector CD4^+^ cells. The names and sizes of the samples being compared are shown at the top of the page, followed by the log-likelihood ratio log(*P*~same~/*P*~diff~) of two models, one which assumes that the frequencies of miRNAs are the same and one that assumes that they can be different between the samples. The log-likelihood ratio takes positive values when the miRNA frequencies are similar and negative values when they are different. In this case, the log-likelihood ratio is positive, indicating that overall, the frequencies of miRNAs in these samples are more likely to have been the same. The list of miRNAs ranked from most dissimilar to most similar expression follows. Each row contains the name of an miRNA, the direction of regulation (up or down), the cloning counts and frequencies in both samples and provides a direct link to the predicted targets of the miRNA. The model indicates that with a 18% versus 54% cloning frequency, and despite the small size of the effector CD4^+^ T-cell sample, miR-142-5p is very likely to be downregulated in effector cells. Again, this can be inferred from the negative value of log(*P*~same~/*P*~diff~) for miR-142-5p. From this page, the user can select one or several miRNAs that came out differentially expressed and can browse the list of predicted targets ([Figure 2](#F2){ref-type="fig"}). In the case of miR-142-5p, the top 10 predicted targets include four transcription factors (AFF4, ONECUT2, ZFPM2 and ZNF148), and a kinase (PRPF4B) involved in pre-RNA splicing. These genes could provide a starting point for experimental studies on the function of miR-142-5p in T lymphocytes. Figure 1.Screenshot of the web page showing the result from comparing miRNA expression of human CD4^+^ effector T cells with the CD4^+^ naive T cells. Details are provided in the text. Figure 2.Screenshot of the web page showing the ElMMo miRNA target predictions for miR-142-5p in all *H. sapiens* RefSeq mRNAs. The target predictions results are organized in two sections. The first section---located on the upper part of the web page---is miRNA-centric and features miRNA target predictions statistics as well as a figure showing the smiRNAdb tissues where the miRNA is mostly expressed. The second, mRNA-centric section is located on the lower part of the web page and provides a ranked list of mRNA predicted to be targeted by miR-142-5p.

Since the original release of smiRNAdb, we have implemented an additional tool for performing principal component analysis on the miRNA expression profiles, we added more possibilities for the user to download miRNA profile data for further processing and we started to incorporate other publicly available small RNA sequencing datasets from *Danio rerio*, *Drosophila melanogaster* and *Caenorhabditis elegans*. We reimplemented the software that was originally written in Perl CGI to use Java Server Faces technology and Apache/Tomcat. The computations are now performed on a computing cluster, with job distribution managed by the Sun Grid Engine queuing system. Finally, we enhanced the result screens of our on-line analysis tools with hyperlinks that directly take the user to the miRNA target predictions within the context of the smiRNAdb query, i.e. preserving the selected organism, miRNAs and tissue (if available). Refer to the web connectivity map in the [Supplementary Material](http://nar.oxfordjournals.org/cgi/content/full/gkp412/DC1) for an overview of the new links between smiRNAdb and ElMMo, as well as of the external ressources that we use in performing various analyses.

The ElMMo miRNA target prediction algorithm based on comparative genomic analysis
---------------------------------------------------------------------------------

To be able to address the question of what mRNA is most likely affected by the change in expression of a miRNA, we coupled smiRNAdb to a PHP-based web interface to the ElMMo miRNA target predictions ([@B18]).

Returning to the example of the hsa-miR-142-5p miRNA that was highlighted in 'The smiRNAdb miRNA expression atlas' section, the web interface allows aside from browsing the predicted targets, a number of other queries. For instance, given an organism (*H. sapiens* in this example), the user can choose to scan for predicted miRNA target sites not only the default set of transcripts, which is all known RefSeq ([@B35]) mRNAs in the chosen organism, but also subsets of transcripts. The SymAtlas project ([@B36]) of the Genomics Institute of the Novartis Research Foundation (GNF) generated microarray-based mRNA expression profiles for a wide range of tissues. These profiles are incorporated in MirZ, giving the user the possibility to restrict target prediction to mRNAs that are expressed in a given cell type. The web interface further allows to scan an arbitrary number of mRNAs for up to 20 miRNAs simultaneously. Alternatively, the user can limit the number of mRNAs to scan to 20 mRNAs and then retrieve predicted target sites in these mRNAs for an arbitrary number of miRNAs.

MiRNAs exert their effector function through ribonucleoprotein complexes (miRNP) that contain, aside from the guiding miRNA a member of the Argonaute family of proteins. The determinants of productive miRNA--target site interactions are not entirely known, but a large body of work ([@B16],[@B37; @B38; @B39; @B40; @B41]) established that perfect complementarity of the 7--8 ns from the 5′-end of the miRNA---the so-called miRNA 'seed'---is critical for target recognition. Although miRNA target sites that do not satisfy this constraint have been described, at the genome-wide level the accuracy of predicting such sites is low ([@B16],[@B18]). Other than perfect seed complementarity, the location of the putative target site within the 3′-UTR ([@B18],[@B25],[@B42]), structural accessibility ([@B21],[@B22],[@B43]), the nucleotide composition in its vicinity ([@B25],[@B26]) and the complementarity of specific positions in the miRNA 3′-end to the target site ([@B25]) have all been reported to improve the accuracy of miRNA target prediction, yet the relative importance of these features remains unknown. The ElMMo miRNA target prediction method that we developed is based on a Bayesian model that only uses comparative genomics information. Yet it has as high an accuracy as other widely used target prediction programs that incorporate additional constraints, and measures of predictive performance on a set of experimentally validated miRNA targets in *D. melanogaster* can be found in the article describing the ElMMo method ([@B18]). Importantly, our model does not have any free parameters, and can easily accommodate additional species whose genome sequence becomes available.

Going back to our example, [Figure 2](#F2){ref-type="fig"} shows the ElMMo predictions for miR-142-5p in *H. sapiens*. This result screen is organized in two sections: (i) a miRNA-centric summary featuring per-miRNA target prediction statistics and a figure showing the smiRNAdb tissues where the selected miRNAs are mostly expressed, and (ii) a mRNA-centric summary that ranks all mRNAs predicted to be targeted by the selected miRNAs. In this later section, mRNAs are ordered by decreasing expected number of miRNA target sites under selective pressure, defined as the sum of all target site posterior probabilities for the selected miRNAs. The location of the putative target sites in the 3′-UTR is also indicated.

From the result screen, the user has the possibility to zoom onto a specific transcript to visualize the multiple genome alignments in the regions of the predicted target sites, and to find additional information about the targeted mRNAs from the Genbank database of the National Center for Biomedical Information (NCBI). Our web service also offers the possibility to run a Gene Ontology (GO) analysis searching for GO terms that are significantly over- or under-represented in the predicted miRNA targets through a modified version of the GeneMerge software ([@B44]). For instance, in the case of miR-142-5p, the most significantly enriched Biological Process GO term is 'regulation of transcription, DNA-dependent' (hypergeometric *P*-value \<10^−10^, after Bonferroni multiple testing correction), followed by two 'muscarinic acetylcholine receptor'-associated GO terms (*P* \< 10^−10^). The muscarinic acetylcholine receptor has been shown to be involved in autocrine control of cell proliferation, including the proliferation of immune cells ([@B45]). This type of analyses could thus provide experimental scientists with clues to the function of miR-142-5p in the naive CD4^+^ T cells.

The current release of ElMMo features miRNA target predictions for *H. sapiens*, *M. musculus*, *R. norvegicus*, *D. rerio*, *C. elegans* and *D. melanogaster*. Of these, the *M. musculus* and *R. norvegicus* predictions were not present in our initial publication ([@B18]). Furthermore, for the remaining organisms, the current predictions are based on the genome sequences of a larger set of species, because more fully sequenced genomes became available since 2007. We further based our predictions on the most recent mRNA sequences and 3′-UTR annotations provided by the RefSeq database ([@B35]). Concerning the microarray profiles that the user can use to guide miRNA target discovery in specific tissues and aside from the *H. sapiens* profiles that were used in our original ElMMo release ([@B18]), we incorporated similar mRNA expression profiles for *M. musculus* and *R. norvegicus*. Finally, the ElMMo web interface now informs the user about the smiRNAdb samples in which the selected miRNAs are most strongly expressed.

Experimental data
-----------------

The miRNA sequences that were used for miRNA sample annotation and for miRNA target prediction were obtained from the miRBase release 12.0 ([@B46]). For the miRNA profiles, MirZ includes a total of 297 samples: 173 for *H. sapiens* ([@B14]), 88 for *M. musculus* ([@B14]), 16 for *R. norvegicus* ([@B14]), 10 for *D. melanogaster* ([@B47]), 9 for *D. rerio* ([@B48]) and 1 for *C. elegans* ([@B49]).

For miRNA target predictions, we used the most recent genome assemblies available at the University of California Santa Cruz (UCSC) ([@B50]): hg18 for *H. sapiens*, mm9 for *M. musculus*, rn4 for *R. norvegicus*, danRer5 for *D. rerio*, ce6 for *C. elegans* and dm3 for *D. melanogaster*. We further used the following UCSC genome assemblies in the pairwise genome alignments: panTro2, rheMac2, mm9, rn4, canFam2, monDom4, bosTau4 and galGal3 for *H. sapiens*; panTro2, rheMac2, hg18, rn4, canFam2, monDom4, bosTau4 and galGal3 for *M. musculus*; panTro2, rheMac2, hg18, mm9, canFam2, monDom4, bosTau3 and galGal3 for *R. norvegicus*; tetNig1, fr2 and oryLat2 for *D. rerio*; caeJap1, caePb2, caeRem3, cb3 and priPac1 for *C. elegans*; and dp4, droAna3, droEre2, droGri2, droMoj3, droPer1, droSec1, droSim1, droVir3, droWil1 and droYak2 for *D. melanogaster*. mRNAs for all organisms were downloaded from the RefSeq database on 21 January 2009.

The links between sequence entities in various databases were made by mapping them all to the Gene database of NCBI ([@B35]). MiRNA expression profiles, microarray mRNA profiles and miRNA target predictions are stored as relational databases managed by a PostgreSQL server ([www.postgresql.org](www.postgresql.org)).

CONCLUSION AND FUTURE DIRECTIONS
================================

Using a concrete example comparing effector to naive CD4^+^ T-cells, we showed how MirZ can help isolating miRNAs that may be involved in a given biological function, and then provide clues into which molecular pathways may be controlled by these miRNAs to achieve their biological function. The integration of miRNA expression profiles with genome-wide miRNA target prediction combined with the tools we implemented---a Bayesian model for sample comparison, multivariate exploratory statistics, GO-term enrichment analysis---makes MirZ a powerful tool for studying miRNA-based regulation.

Since its publication, the miRNA expression atlas has been a valuable resource to the research community, and with the more general availability of deep sequencing technologies, more miRNA expression datasets are expected to emerge. Being able to explore and compare these datasets in a unified framework is highly desirable, and we plan to further support such analyses by updating MirZ as new datasets become available. Particularly for *D. melanogaster*, we currently only incorporate small-sized samples, and for *C. elegans* a whole-worm sample.

The target prediction methods also continue to evolve. In particular, additional determinants of miRNA targeting specificity must exist because not all transcripts that contain miRNA seed matches respond in a given experiment, but what these determinants are is still an open question ([@B25],[@B26]). If a significantly better target prediction method emerges, this could be incorporated in our server.

SUPPLEMENTARY DATA
==================
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